Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis.
about
Iron dysregulation in Huntington's diseaseMagnetic resonance imaging striatal volumes: a biomarker for clinical trials in Huntington's diseaseCorrelations of behavioral deficits with brain pathology assessed through longitudinal MRI and histopathology in the R6/2 mouse model of HDCorrelations of behavioral deficits with brain pathology assessed through longitudinal MRI and histopathology in the R6/1 mouse model of Huntington's diseasePrefrontal cortex white matter tracts in prodromal Huntington diseaseNeuroimaging biomarkers of neurodegenerative diseases and dementiaCompensation in Preclinical Huntington's Disease: Evidence From the Track-On HD StudyAn International Survey-based Algorithm for the Pharmacologic Treatment of Chorea in Huntington's DiseaseCurrent Status of Huntington's Disease in Korea: A Nationwide Survey and National Registry AnalysisThe long-term safety and efficacy of bilateral transplantation of human fetal striatal tissue in patients with mild to moderate Huntington's diseaseHdac6 knock-out increases tubulin acetylation but does not modify disease progression in the R6/2 mouse model of Huntington's diseaseMolecular Imaging Markers to Track Huntington’s Disease PathologyMusic perception and movement deterioration in Huntington's disease.Phonatory dysfunction as a preclinical symptom of Huntington disease.Abnormal synchrony of resting state networks in premanifest and symptomatic Huntington disease: the IMAGE-HD study.Objective acoustic quantification of phonatory dysfunction in Huntington's diseaseCognitive reserve and brain reserve in prodromal Huntington's disease.A two years longitudinal study of a transgenic Huntington disease monkey.Functional magnetic resonance imaging of working memory in Huntington's disease: cross-sectional data from the IMAGE-HD study.Dynamics of the connectome in Huntington's disease: A longitudinal diffusion MRI study.Multi-modal neuroimaging in premanifest and early Huntington's disease: 18 month longitudinal data from the IMAGE-HD study.Functional changes during working memory in Huntington's disease: 30-month longitudinal data from the IMAGE-HD study.Neuroimaging in Huntington's disease.Attempted and successful compensation in preclinical and early manifest neurodegeneration - a review of task FMRI studiesRobust MR-based approaches to quantifying white matter structure and structure/function alterations in Huntington's disease.Molecular Imaging of Huntington's Disease.Presentation and care of a family with Huntington disease in a resource-limited community.Topological length of white matter connections predicts their rate of atrophy in premanifest Huntington's disease.Attenuated pupillary light responses and downregulation of opsin expression parallel decline in circadian disruption in two different mouse models of Huntington's diseaseMetformin intake associates with better cognitive function in patients with Huntington's disease.The stress response factor daf-16/FOXO is required for multiple compound families to prolong the function of neurons with Huntington's diseaseHuntingtin protein is essential for mitochondrial metabolism, bioenergetics and structure in murine embryonic stem cellsDifferential putaminal morphology in Huntington's disease, frontotemporal dementia and Alzheimer's disease.[The presymptomatic stage of neurodegenerative disorders].Self Reports of Day-to-Day Function in a Small Cohort of People with Prodromal and Early HD.Longitudinal Change in Gait and Motor Function in Pre-manifest Huntington's Disease.Assessment of cognitive symptoms in prodromal and early huntington disease.Striatal morphology as a biomarker in neurodegenerative disease.Regionally selective atrophy of subcortical structures in prodromal HD as revealed by statistical shape analysis.Differential loss of thalamostriatal and corticostriatal input to striatal projection neuron types prior to overt motor symptoms in the Q140 knock-in mouse model of Huntington's disease.
P2860
Q26829932-99ABB650-2D2F-4D10-9F48-C3D55B8C5129Q27004343-BD29527D-8CF1-4777-8F93-7A4EC987163FQ27332203-D0CA0169-D952-489F-9707-533BD817E9AFQ27334759-ACA93954-24DD-46F6-98C3-47DA0DB0BACAQ27335055-ADC4AF9F-AEE9-4543-927C-37DFE3E2885BQ27691820-E26369F7-3A61-4A25-93DE-0FA9287D925AQ28393234-ECCB0932-028F-429C-8497-280A2F5A9477Q28476791-A3FAAC3A-3D11-4E70-9CC4-D8464C2EE961Q28652090-0BD08D90-D326-4A0B-A87F-6E6A9844BC78Q28705237-AA56A088-9F69-4334-86C8-B95D505DCF60Q28743929-B7435D16-B3EF-48FF-9758-DB1A83DE4EFAQ29248766-94AD4E43-C6D1-4991-A6F7-30E402609FBCQ30407344-C06FC4FF-B747-40BC-A74D-5C4FDCF439DFQ30425545-EF82B938-A324-4A7D-948F-FC1BEEF3255BQ30441887-05D4B578-4535-4BB4-87A4-43E28203EB1EQ30453596-BC343579-16CB-4503-99DB-73E939A6C58DQ30541757-85CBB7D2-7B47-49A7-B8A6-E28840890F4FQ30577737-D3A5BEB6-8BAC-4D7A-A7FD-84D97AF094AAQ30659199-0CCA1D0B-58BA-4BD1-88B9-40D905257951Q30661031-D3261FD5-5EDA-4038-AD6A-AF8A6C871E83Q30670030-F8F715F5-613E-485F-BF55-0B2681E17C98Q30696281-5A9A0E16-D3D3-4331-B6B3-6C017DB71C2FQ30834004-51FFEA88-274C-4301-8AE9-53D9F49C4C63Q30862037-555304EA-7390-42EA-9941-7B8463506C0CQ30991345-4E033A9F-4846-40B5-A030-BB93A6928778Q31139686-723F4209-FA2F-4E62-B57D-4AA952043676Q33556293-073A52F7-3009-4765-BEAB-B699583C66B8Q33579030-14F8873F-D223-41E0-B256-33D9DE5016CDQ33640990-A8D4E7A6-66BA-4FD8-BCB3-BC40B6D60DD6Q33817346-E90D256C-4C99-4766-8A9E-9756F57BB99FQ33822501-7B8840D2-D7D9-4C9F-98F3-2EF3521A53DDQ33945927-7C1AA5CB-9631-4649-A303-FC9698A9730FQ33959500-235A6DB8-5E25-4EC4-ACD4-E00AAB2A4D07Q33971542-15542B6D-D5B2-4C65-91A1-1877718E2BE3Q34013839-FA4E4C7A-C5FA-42F5-AFAD-99B978F6E44DQ34050993-8B92BCAB-7837-4973-9E6D-948E11C14822Q34084492-DABBB804-C9FC-4BC3-A97C-F087D630ED63Q34268646-AD4A9291-7FF9-4169-B622-CA4B6A671B79Q34320446-8B689013-2A92-485F-B100-B7F8C5D6777AQ34341619-7F32C59C-4CF0-412D-B930-95CA3096AF90
P2860
Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Biological and clinical change ...... 2-month longitudinal analysis.
@en
Biological and clinical change ...... 2-month longitudinal analysis.
@nl
type
label
Biological and clinical change ...... 2-month longitudinal analysis.
@en
Biological and clinical change ...... 2-month longitudinal analysis.
@nl
prefLabel
Biological and clinical change ...... 2-month longitudinal analysis.
@en
Biological and clinical change ...... 2-month longitudinal analysis.
@nl
P2093
P50
P1433
P1476
Biological and clinical change ...... 2-month longitudinal analysis.
@en
P2093
Christopher Kennard
G Bernhard Landwehrmeyer
Raymund Ac Roos
Rebecca Jones
Stephen L Hicks
TRACK-HD Investigators
P356
10.1016/S1474-4422(10)70276-3
P50
P577
2010-12-02T00:00:00Z